IRIS
CASTAGNA, MARIA GRAZIA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 5.573
NA - Nord America 4.983
AS - Asia 684
AF - Africa 40
OC - Oceania 17
SA - Sud America 13
Continente sconosciuto - Info sul continente non disponibili 4
Totale 11.314
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.967
GB - Regno Unito 1.316
IT - Italia 1.156
IE - Irlanda 1.139
RU - Federazione Russa 513
SE - Svezia 492
CN - Cina 308
UA - Ucraina 252
SG - Singapore 246
FR - Francia 230
DE - Germania 168
FI - Finlandia 136
ES - Italia 48
CI - Costa d'Avorio 32
IN - India 32
NL - Olanda 31
BE - Belgio 24
TR - Turchia 24
IR - Iran 21
AU - Australia 16
CZ - Repubblica Ceca 15
PL - Polonia 14
CA - Canada 13
VN - Vietnam 13
BR - Brasile 7
JP - Giappone 7
HK - Hong Kong 6
LU - Lussemburgo 5
RO - Romania 5
EU - Europa 4
JO - Giordania 4
MA - Marocco 4
MK - Macedonia 4
AT - Austria 3
EG - Egitto 3
GR - Grecia 3
IL - Israele 3
LT - Lituania 3
SA - Arabia Saudita 3
AE - Emirati Arabi Uniti 2
AM - Armenia 2
AR - Argentina 2
BG - Bulgaria 2
BO - Bolivia 2
CH - Svizzera 2
CR - Costa Rica 2
IM - Isola di Man 2
IQ - Iraq 2
KR - Corea 2
KZ - Kazakistan 2
PH - Filippine 2
PT - Portogallo 2
UZ - Uzbekistan 2
AL - Albania 1
BY - Bielorussia 1
DK - Danimarca 1
EC - Ecuador 1
IS - Islanda 1
JM - Giamaica 1
KG - Kirghizistan 1
LA - Repubblica Popolare Democratica del Laos 1
LV - Lettonia 1
MT - Malta 1
NZ - Nuova Zelanda 1
PE - Perù 1
SK - Slovacchia (Repubblica Slovacca) 1
SM - San Marino 1
TM - Turkmenistan 1
ZA - Sudafrica 1
Totale 11.314
Salva come PNG Salva come JPEG
Città #
Southend 1.241
Dublin 1.115
Fairfield 766
Santa Clara 471
Chandler 420
Ashburn 369
Woodbridge 342
Wilmington 293
Houston 276
Seattle 275
Cambridge 268
Siena 229
Ann Arbor 222
Singapore 196
Florence 182
Jacksonville 175
Princeton 146
Helsinki 109
San Mateo 69
Moscow 63
Beijing 59
Shanghai 55
Nanjing 50
Rome 47
Milan 43
San Diego 39
New York 38
Málaga 37
Abidjan 32
Boardman 31
Dearborn 30
Saint Petersburg 29
Brussels 23
London 20
Naples 20
Munich 17
Redwood City 17
Prato 16
Düsseldorf 14
Fremont 13
Izmir 13
Jiaxing 12
Los Angeles 12
Norwalk 12
Dong Ket 11
Nanchang 11
Ponte Buggianese 11
Ravenna 11
Zhengzhou 11
Brno 10
Kunming 10
Tianjin 10
Washington 10
Zanjan 10
Bari 9
Bologna 9
Chicago 9
Pisa 9
Amsterdam 8
Guangzhou 7
Hangzhou 7
Hebei 7
Lappeenranta 7
Livorno 7
Toronto 7
Clifton 6
Melbourne 6
Modena 6
Ningbo 6
Padova 6
Salerno 6
San Francisco 6
Shenyang 6
Stockholm 6
Turin 6
Aachen 5
Columbus 5
Dallas 5
Jinan 5
Kilburn 5
Lancaster 5
Lugo 5
Luxembourg 5
Montevarchi 5
Palermo 5
Perugia 5
Pistoia 5
Poggibonsi 5
Sesto Fiorentino 5
Sydney 5
Amman 4
Cagliari 4
Changsha 4
Colle di Val d'Elsa 4
Cosenza 4
Delhi 4
Enna 4
Falkenstein 4
Falls Church 4
Figline Valdarno 4
Totale 8.272
Salva come PNG Salva come JPEG
Nome #
Blockade of the programmed death ligand 1 (PD-L1) as potential therapy for anaplastic thyroid cancer 240
Small papillary thyroid carcinoma with minimal extrathyroidal extension should be managed as ATA low-risk tumor 239
CONUT Score: A New Tool for Predicting Prognosis in Patients with Advanced Thyroid Cancer Treated with TKI 231
G-protein coupled receptors (GPCRs) in the treatment of diabetes: Current view and future perspectives 227
Nodules in autoimmune thyroiditis are associated with increased risk of thyroid cancer in surgical series but not in cytological series: evidence for selection bias 215
Obesity Does Not Modify the Risk of Differentiated Thyroid Cancer in a Cytological Series of Thyroid Nodules 214
Chronic lymphocytic thyroiditis (CLT) has a positive prognostic value in papillary thyroid cancer (PTC) patients: the potential key role of Foxp3+ T lymphocytes 209
Reference range of serum calcitonin in pediatric population 201
Post-surgical thyroid ablation with low or high radioiodine activities results in similar outcomes in intermediate risk differentiated thyroid cancer patients 197
Rare POMC Mutation in a Patient With Myotonic Dystrophy Type 1 and Adrenocorticotropin Hyperresponse to Corticotropin-Releasing Hormone 193
FASTING ENHANCES TKI EFFICACY ON THYROID CANCER CELLS 182
DIO2 Thr92Ala reduces deiodinase-2 activity and serum-T3 levels in thyroid-deficient patients 178
MicroRNA expression profile of thyroid nodules in fine-needle aspiration cytology: a confirmatory series 178
Acute exogenous TSH administration stimulates leptin secretion in vivo 172
Clinical significance of type 2 iodothyronine deiodinase polymorphism 169
Approach to and treatment of differentiated thyroid carcinoma 168
Shorter androgen receptor polyQ alleles protect against life-threatening COVID-19 disease in European males 162
Large-scale screening of organ specific autoantibodies in patients with autoimmune thyroid diseases 159
One month weight loss predicts the efficacy of liraglutide in obese patients: Data from a single center 152
Lack of association between urinary iodine excretion and successful thyroid ablation in thyroid cancer patients 151
Variants in MCT10 protein do not affect FT3 levels in athyreotic patients 151
Thyroid cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up 150
Multiple endocrine neoplasia type 2 syndromes (MEN 2): results from the ItaMEN network analysis on the prevalence of different genotypes and phenotypes 147
Delayed risk stratification, to include the response to initial treatment (surgery and radioiodine ablation), has better outcome predictivity in differentiated thyroid cancer patients 147
Medullary thyroid carcinoma 146
Long-term efficacy of modified-release recombinant human thyrotropin augmented radioiodine therapy for benign multinodular goiter: results from a multicenter, international, randomized, placebo-controlled, dose-selection study 143
Thyroid cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up 143
Role of age at diagnosis in defining potential familial nonmedullary thyroid cancer in kindreds with two affected members 137
Reappraisal of the indication for radioiodine thyroid ablation in differentiated thyroid cancer patients 136
Androgen Deprivation Therapy for Prostatic Cancer in Patients With Torsades de Pointes 135
Long-Term Clinical Outcome in Familial and Sporadic Papillary Thyroid Carcinoma 134
null 126
Effects of Acute Recombinant Human TSH on Serum Ghrelin Levels 118
Molecular signature of indeterminate thyroid lesions: Current methods to improve fine needle aspiration cytology (FNAC) diagnosis 116
Screening and detecting significant liver fibrosis in patients with NAFLD: A practical approach using non-invasive tests 115
Dual energy CT in gland tumors: a comprehensive narrative review and differential diagnosis 114
BROX haploinsufficiency in familial nonmedullary thyroid cancer 113
Prospective Validation of ATA and ETA Sonographic Pattern Risk of Thyroid Nodules Selected for FNAC 112
HABP2 G534E variation in familial non-medullary thyroid cancer: an Italian series 109
Calcitonin Levels in Thyroid Disease Are Not Affected by Autoimmune Thyroiditis or Differentiated Thyroid Carcinoma 109
Eif1ax c.338-2a>t splice site mutation in a patient with trabecular adenoma and cytological indeterminate lesion 108
Validation of American Thyroid Association Ultrasound Risk-Adapted Approach for Repeating Cytology in Benign Thyroid Nodules 108
Indication for radioiodine remnant ablation in differentiated thyroid cancer patients: does 2018 Italian consensus change anything? 106
New insight in the follow-up strategies of differentiated thyroid cancer 105
Modified-release recombinant human TSH (MRrhTSH) augments the effect of (131)I therapy in benign multinodular goiter: results from a multicenter international, randomized, placebo-controlled study 104
Preliminary results from whole-genome expression analysis in patients with secondary adrenal insufficiency treated with modified-release hydrocortisone 102
Baseline serum TSH levels predict the absence of thyroid dysfunction in cancer patients treated with immunotherapy 101
Should familial disease be considered as a negative prognostic factor in micropapillary thyroid carcinoma? 99
Autoimmune thyroid diseases are more common in patients with prolactinomas: a retrospective case–control study in an Italian cohort 98
RET/PTC3 rearrangement and thyroid differentiation gene analysis in a struma ovarii fortuitously revealed by elevated serum thyroglobulin concentration 98
8th edition of the AJCC/TNM staging system of thyroid cancer: What to expect (ITCO#2) 97
Nodular Thyroid Disease in the Era of Precision Medicine 96
Alteration of Serum Proteome in Levo-Thyroxine-Euthyroid Thyroidectomized Patients 93
Familial non-medullary thyroid cancer: a critical review 90
Screening of organ-specific autoantibodies in a large cohort of patients with autoimmune thyroid diseases. 90
The use of ultrasensitive thyroglobulin assays reduces but does not abolish the need for TSH stimulation in patients with differentiated thyroid carcinoma 87
Long-term Effects of Radioiodine in Toxic Multinodular Goiter: Thyroid Volume, Function, and Autoimmunity 85
Controlling Nutritional Status (CONUT) Score and Micronutrient Deficiency in Bariatric Patients: Midterm Outcomes of Roux-en-Y Gastric Bypass Versus One Anastomosis Gastric Bypass/Mini Gastric Bypass 85
Monitoraggio del nodulo tiroideo benigno in accordo con la classe di rischio ecografica 84
Response Letter to the Editor from Edmundo Avila-Hipolito: "Long-term effects of radioiodine in toxic multinodular goitre: thyroid volume, function and autoimmunity" 83
A comparison of 1850 (50 mCi) and 3700 MBq (100 mCi) 131-iodine administered doses for recombinant thyrotropin-stimulated postoperative thyroid remnant ablation in differentiated thyroid cancer 82
Permanent diabetes insipidus in a patient with mesothelioma treated with immunotherapy 82
Thr92Ala polymorphism in the type 2 deiodinase gene: an evolutionary perspective 81
Transient hypogonadism is associated with heart rate-corrected QT prolongation and torsades de pointes risk during active systemic inflammation in men 76
Features and outcome of differentiated thyroid carcinoma associated with Graves’ disease: results of a large, retrospective, multicenter study 75
Pilot study on the impact of polymorphisms linked to multi-kinase inhibitor metabolism on lenvatinib side effects in patients with advanced thyroid cancer 74
Ablation of thyroid residues with 30 mCi 131I: A comparison in thyroid cancer patients prepared with recombinant human TSH or thyroid hormone withdrawal 73
Vemurafenib may overcome TNF-related apoptosis-inducing ligand (TRAIL) resistance in anaplastic thyroid cancer cells 72
Limited value of repeat recombinant human thyrotropin (rhTSH)-stimulated thyroglobulin testing in differentiated thyroid carcinoma patients with previous negative rhTSH-stimulated thyroglobulin and undetectable basal serum thyroglobulin levels 71
Real-world efficacy and safety of lenvatinib: data from a compassionate use in the treatment of radioactive iodine-refractory differentiated thyroid cancer patients in Italy 71
Prediction of disease status by recombinant human TSH-stimulated serum Tg in the postsurgical follow-up of differentiated thyroid carcinoma 71
Real-world performance of ATA risk estimates in predicting 1-year DTC outcomes: A prospective multicenter study of 2000 patients (ITCO Study #3) 70
A case of papillary thyroid cancer without aggressive histological features with nodal metastases detected during follow-up in a younger patients 69
Changes in both size and cytological features of thyroid nodule after levothyroxine treatment 69
Incidental findings of anti-mitochondrial antibodies without evidence of Primary Biliary Cholangitis. 69
Pregnancy-associated plasma protein A mRNA expression as a marker for differentiated thyroid cancer: results from a "surgical" and a "cytological" series 67
Radioiodine therapy in the different stages of differentiated thyroid cancer 65
Risk of second malignant neoplasm in familial non-medullary thyroid cancer patients 64
Differentiated thyroid cancer: ESMO clinical recommendations for diagnosis, treatment and follow-up 64
Attention deficit and hyperactivity disorders in the offspring of mothers exposed to mild-moderate iodine deficiency: A possible novel iodine deficiency disorder in developed countries 64
Silent thyroiditis following vaccination against COVID-19: report of two cases 61
Diagnostic and therapeutic use of recombinant human TSH (rhTSH) in differentiated thyroid cancer 60
Recombinant human thyrotropin-stimulated serum thyroglobulin combined with neck ultrasonography has the highest sensitivity in monitoring differentiated thyroid carcinoma 60
European consensus for the management of patients with differentiated thyroid carcinoma of the follicular epithelium 60
Differentiated thyroid cancer: ESMO clinical recommendations for diagnosis, treatment and follow-up 57
Analytical performance of free testosterone calculated by direct immunoluminometric method compared with the Vermeulen equation: results from a clinical series 53
RET/PTC3 rearrangement and thyroid differentiation gene analysis in a struma ovarii fortuitously revealed by elevated serum thyroglobulin concentration 53
Prognostic Factors Improving ATA Risk System and Dynamic Risk Stratification in low and Intermediate DTC Patients 53
A case of papillary thyroid cancer without aggressive histological features with nodal metastyases in an older patients 52
Lean body mass is a major determinant of levothyroxine dosage in the treatment of thyroid diseases 52
Thyroid cancer- A case-Based Approach 52
Influence of human body composition on serum peak thyrotropin (TSH) after recombinant human TSH administration in patients with differentiated thyroid carcinoma 52
Autosomal dominant familial neurohypophyseal diabetes insipidus caused by a novel missense mutation in AVP gene in a large Italian kindred 51
Normalization of Spexin Levels in Patients with Obesity Submitted to Bariatric Surgery 51
Failure to use measurement of megalin secretory components complexed with serum thyroglobulin as a tool to identify metastases after surgery in papillary thyroid cancer 49
Video assisted prophylactic thyroidectomy and central compartment nodes clearance in two RET gene mutation adult carriers 48
From Circulating Tumor Cells to Mirna: New Challenges in the Diagnosis and Prognosis of Medullary Thyroid Cancer 47
Dynamic Risk Stratification Integrated with ATA Risk System for Predicting Long-Term Outcome in Papillary Thyroid Cancer 46
Increased risk of maternal thyroid failure with pregnancy progression in an iodine deficient area with major iodine deficiency disorders 46
Il carcinoma familiare non midollare della tiroide non sindromico 45
Totale 10.834
Salva come PNG Salva come JPEG
Categoria #
all - tutte 48.356
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 48.356
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020828 0 0 0 0 0 0 144 157 138 105 49 235
2020/20212.106 55 213 67 206 187 285 114 330 153 266 115 115
2021/20221.375 120 110 112 147 78 87 38 51 81 151 168 232
2022/20231.802 111 219 223 202 132 369 78 123 170 68 54 53
2023/20241.990 67 48 161 123 138 411 671 78 43 39 44 167
2024/20251.822 96 185 478 275 474 304 10 0 0 0 0 0
Totale 11.714